StockData
NovoCure Ltd logo

NovoCure Ltd (NVCR) stock

NVCRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 9/3034% below fair value
$10.71+0.02 (+0.19%)

Close on Nov 20, 2026Market cap $1.25BP/E –Yield –

NovoCure shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

NovoCure's shares outstanding was 117M at Sep 30, 2026. For fiscal 2025 it was 111M, up 3.4% from the year before. Over ten years it grew 13.9% a year on average. The highest annual figure on record is 111M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 2025111M+3.4%
FY2024Dec 31, 2024108M+1.4%
FY2023Dec 31, 2023106M+1.7%
FY2022Dec 31, 2022105M+1.2%
FY2021Dec 31, 2021103M-5.0%
FY2020Dec 31, 2020109M+12.0%
FY2019Dec 31, 201997M+5.9%
FY2018Dec 31, 201892M+3.7%
FY2017Dec 31, 201789M+3.5%
FY2016Dec 31, 201686M+181.4%
FY2015Dec 31, 201530M+143.4%
FY2014Dec 31, 201412M+8.6%
FY2013Dec 31, 201311M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026117M+4.4%
Q2 FY2026Jun 30, 2026116M+4.0%
Q1 FY2026Mar 31, 2026114M+3.5%
Q4 FY2025Dec 31, 2025112M+3.5%
Q3 FY2025Sep 30, 2025112M+3.4%
Q2 FY2025Jun 30, 2025112M+3.6%
Q1 FY2025Mar 31, 2025110M+2.8%
Q4 FY2024Dec 31, 2024108M+1.3%
Q3 FY2024Sep 30, 2024108M+1.4%
Q2 FY2024Jun 30, 2024108M+1.3%
Q1 FY2024Mar 31, 2024107M+1.5%
Q4 FY2023Dec 31, 2023107M+1.8%
Q3 FY2023Sep 30, 2023107M+1.8%
Q2 FY2023Jun 30, 2023106M+1.6%
Q1 FY2023Mar 31, 2023106M+1.4%
Q4 FY2022Dec 31, 2022105M+1.1%
Q3 FY2022Sep 30, 2022105M+1.1%
Q2 FY2022Jun 30, 2022105M+1.1%
Q1 FY2022Mar 31, 2022104M+1.5%
Q4 FY2021Dec 31, 2021104M-6.1%
Q3 FY2021Sep 30, 2021104M-4.5%
Q2 FY2021Jun 30, 2021103M-3.9%
Q1 FY2021Mar 31, 2021103M-5.1%
Q4 FY2020Dec 31, 2020111M+2.5%
Q3 FY2020Sep 30, 2020109M+1.0%
Q2 FY2020Jun 30, 2020108M+11.7%
Q1 FY2020Mar 31, 2020108M+14.0%
Q4 FY2019Dec 31, 2019108M+15.9%
Q3 FY2019Sep 30, 2019108M+15.8%
Q2 FY2019Jun 30, 201996M+5.5%
Q1 FY2019Mar 31, 201995M+5.4%
Q4 FY2018Dec 31, 201893M+4.1%
Q3 FY2018Sep 30, 201893M+4.2%
Q2 FY2018Jun 30, 201891M+3.5%
Q1 FY2018Mar 31, 201890M+2.9%
Q4 FY2017Dec 31, 201789M+3.0%
Q3 FY2017Sep 30, 201789M–
Q2 FY2017Jun 30, 201788M–
Q1 FY2017Mar 31, 201787M–
Q4 FY2016Dec 31, 201687M–

More NovoCure figures

See a number that looks wrong?